Saturday, October 11, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

JP Morgan Analyst Upgrades Axon Enterprise to Overweight with 330 Price Target

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Finance_Fiscal (3)
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Analyst Paul Chung from JP Morgan has recently boosted Axon Enterprise (NASDAQ: AXON) to an Overweight rating and increased the price target to $330. This upgrade showcases a bullish view on the company’s potential growth and performance. As of February 28, 2024, Axon’s average one-year price target stands at $252.47, with predictions ranging from $225.23 to a high of $330. JP Morgan’s upgrade indicates a strong belief in Axon’s future outlook and financial success.

AXON Stock Shows Strong Performance with After-Hours Surge on February 28, 2024

On February 28, 2024, AXON stock demonstrated strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. According to data from CNN Money, the price of AXON shares closed at $271.82, representing a $0.23 increase since the market last closed, a 0.08% rise.

Following the market close, AXON stock continued to show positive momentum in after-hours trading, with the stock price rising by $11.18. This significant increase further indicates the bullish sentiment surrounding AXON and suggests that investors are optimistic about the company’s future prospects.

AXON Stock Analysis: Strong Revenue Growth but Decrease in EPS Raises Concerns

On February 28, 2024, AXON stock showed strong performance based on the financial data provided by CNN Money. The company reported a total revenue of $1.56 billion for the past year, which represents a significant increase of 31.38% compared to the previous year. Additionally, the total revenue for the fourth quarter of the year was $432.14 million, showing a 4.48% increase compared to the previous quarter.

In terms of net income, AXON reported a net income of $174.23 million for the past year, reflecting an 18.41% increase compared to the previous year. However, the net income for the fourth quarter was $57.27 million, which remained flat compared to the previous quarter.

Earnings per share (EPS) for AXON were $2.31 for the past year, showing a 13.87% increase compared to the previous year. However, the EPS for the fourth quarter was $0.75, representing a 4.09% decrease compared to the previous quarter.

Overall, AXON stock showed positive growth in terms of total revenue and net income compared to the previous year. However, the decrease in EPS for the fourth quarter may have caused some concern among investors. It will be interesting to see how AXON continues to perform in the upcoming quarters and whether they can sustain their growth trajectory. Investors should closely monitor the company’s financial reports and market performance to make informed decisions regarding their investments in AXON stock.

Tags: AXON
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Revolutionary Weight Loss Implants by Vivani Medical A GameChanger in Obesity Treatment

Finance_Investment (2)

Analyst Upgrades Carlyle Secured Lending to Neutral Rating and Raises Price Target

Telecommunications Industry Stock Exchange

Globalstar Reports Strong Sales Growth and Positive Outlook for Fiscal Year 2024

Recommended

AxoGen Stock

AxoGen Stock: Could an Upcoming FDA Ruling Transform the Company’s Trajectory?

2 months ago

Movanos Stock Surges as US Patent Application Nears Approval

2 years ago
Eutelsat Communications Stock

Eutelsat Shares Surge on Massive Undervaluation Report

2 days ago
Cintas Stock

Cintas Stock Approaches Critical Juncture Ahead of Earnings

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ocugen Receives Key FDA Clearance to Advance Eye Disease Treatment

ImageneBio Charts New Course Following Merger Completion

Method Electronics: A Stock at a Critical Crossroads

Abeona Therapeutics Stock Shows Signs of Recovery After Key Commercial Progress

Acquisition Finalized: Faro Shareholders Approve AMETEK’s Premium Buyout

Zumiez Stock: A Valuation Disconnected from Reality

Trending

MicroStrategy Stock
Blockchain

MicroStrategy Shares Hit by Renewed US-China Trade Fears

by Dieter Jaworski
October 11, 2025
0

Friday's trading session delivered an unexpected blow to MicroStrategy investors as escalating trade tensions between the United...

Alphabet Stock

Regulatory Pressure Mounts on Alphabet as UK Designates Search Dominance

October 11, 2025
Broadcom Stock

Broadcom Shares Face Pressure After AI-Driven Rally

October 11, 2025
Ocugen Stock

Ocugen Receives Key FDA Clearance to Advance Eye Disease Treatment

October 11, 2025
Ikena Oncology Stock

ImageneBio Charts New Course Following Merger Completion

October 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MicroStrategy Shares Hit by Renewed US-China Trade Fears
  • Regulatory Pressure Mounts on Alphabet as UK Designates Search Dominance
  • Broadcom Shares Face Pressure After AI-Driven Rally

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com